Albania

Reimbursed Care Access

Most classical and novel psychedelic compounds (psilocybin, MDMA, DMT family, mescaline, 2C‑X, ibogaine, ayahuasca) are listed as controlled/hallucinogenic substances in Albanian law and have no authorized medical use outside approved research. Ketamine is routinely procured and used in Albanian hospitals for anesthesia and emergency care but use for psychiatric indications is off‑label and not part of any publicly reimbursed, standardized psychedelic‑assisted therapy program. Esketamine (Spravato) does not appear on Albania’s national marketing/registration materials and has no known national reimbursement pathway or approved psychiatric indication in Albania.